Drainage devices and methods for use
Devices and methods for draining excess lymph fluid are disclosed. The device can be fixed to the blood vessel adjacent to the thoracic duct. The device can have a port for withdrawing lymph fluid exiting the thoracic duct. The device can have a cannula and/or subcutaneous port to draw the lymph fluid away from the thoracic duct and reduce hemostatic pressure in the lymphatic system.
1. A method for reducing interstitial volume in a patient's body using a device comprising a tubular member including a distal end placed into a venous system of the patient's body such that the distal end is located outside an outlet of a thoracic duct of the patient's body and a subcutaneous access port implanted within the patient's body and coupled to the tubular member, the method comprising:
expanding proximal and distal balloons on the distal end to substantially isolate the thoracic duct from the patient's venous system;
accessing the access port using a needle;
draining fluid from the thoracic duct through a lumen of the tubular member and the needle to a location outside the patient's body to reduce fluid volume within the patient's body; and
discontinuing draining fluid and removing the needle from the access port when the fluid volume is sufficiently reduced.
2. The method of in claim 1 , wherein placing the distal end comprises aligning a port on the distal end with the outlet such that flow from the thoracic duct is directed through the tubular member to drain fluid from the lymphatic system.
3. The method of claim 1 , further comprising applying negative pressure to the lumen to increase fluid flow from the thoracic duct through the needle.
4. The method of claim 1 , wherein the proximal and distal balloons maintain the tubular member in a substantially fixed position relative to the thoracic duct when expanded.
5. The method of claim 1 , further comprising resuming draining fluid from the lymphatic system via the thoracic duct when pressure in the thoracic duct exceeds a predetermined threshold.
6. The method of claim 5 , wherein the predetermined threshold is about twenty five millimeters of Mercury pressure (25 mm Hg).
7. The method of claim 1 , wherein the proximal and distal balloons are positioned on opposite sides of the thoracic duct outlet.
8. The method of claim 7 , wherein a port is provided on the distal end between the proximal and distal balloons that communicates with the lumen, and wherein the proximal and distal balloons are positioned such that the port is adjacent the thoracic duct outlet.
9. The method of claim 1 , wherein the proximal and distal balloons are only expanded when drainage is required.
10. The method of claim 1 , wherein the tubular member allows venous blood flow to continue when the balloons are inflated.
11. The method of claim 1 , further comprising returning at least a portion of the removed fluid back into the patient's body.
12. The method of claim 11 , wherein the removed fluid is processed before returning at least a portion of the removed fluid back into the patient's body.
13. The method of claim 1 , wherein the proximal and distal balloons are expanded when the tubular member is placed into the venous system.
14. The method of claim 1 , wherein the fluid is drained from the thoracic duct using a syringe coupled to the needle.
15. The method of claim 1 , wherein the access port is implanted through an incision in a chest of the patient's body.
16. The method of claim 1 , further comprising:
reaccessing the access port using a needle; and
draining fluid from the thoracic duct through a lumen of the tubular member and the needle to a location outside the patient's body to further reduce fluid volume within the patient's body.
17. A method for decreasing lymphocyte numbers in a patient's body affected by autoimmune or infectious disease using a device comprising a tubular member including a distal end placed into a venous system of the patient's body such that the distal end is located outside an outlet of a thoracic duct of the patient's body and a subcutaneous access port implanted within the patient's body and coupled to the tubular member, the method comprising:
expanding proximal and distal balloons on the distal end to substantially isolate the thoracic duct from the patient's venous system;
accessing the access port using a needle; and
draining fluid from the thoracic duct through a lumen of the tubular member and the needle to a location outside the patient's body.
18. The method of claim 17 , wherein a port on the distal end of the tubular member is aligned with the outlet such that flow from the thoracic duct is directed through the tubular member to drain fluid from the lymphatic duct.
19. The method of claim 17 , further comprising applying negative pressure to the lumen to increase fluid flow from the thoracic duct through the needle.
20. The method of claim 17 , wherein the proximal and distal balloons maintain the tubular member in a substantially fixed position relative to the thoracic duct when expanded.
21. The method of claim 17 , further comprising:
analyzing lymphocytes in the fluid drained from the thoracic duct to identify a subset of lymphocytes;
removing the identified subset of lymphocytes from the fluid; and
returning the fluid into the patient's body after removing the identified subset of lymphocytes.
22. The method of claim 17 , further comprising:
analyzing lymphocytes in the fluid drained from the thoracic duct;
processing the fluid outside the patient's body; and
returning the fluid into the patient's body.
23. A method for evaluating interstitial fluid status within a patient's body using a device comprising a tubular member including a distal end placed into a venous system of the patient's body such that the distal end is located outside an outlet of a thoracic duct of the patient's body and a subcutaneous access port implanted within the patient's body and coupled to the tubular member, comprising:
measuring pressure within the tubular member distal end to approximate lymphatic pressure within the thoracic duct;
providing an alert outside the patient's body when the measured pressure within the tubular member exceeds a predetermined threshold;
accessing the access port using a needle; and
removing interstitial fluid from the thoracic duct via the tubular member and the needle to a location outside the patient's body until the measured pressure falls below the predetermined threshold.
24. The method of claim 23 , further comprising expanding proximal and distal balloons on the distal end to substantially isolate the thoracic duct from the patient's venous system before removing interstitial fluid from the thoracic duct.
25. The method of claim 24 , wherein the distal end is placed to position the proximal and distal balloons on opposite sides of the thoracic duct outlet.
26. The method of claim 25 , wherein a port is provided on the distal end between the proximal and distal balloons that communicates with a lumen of the tubular member, and wherein the proximal and distal balloons are positioned such that the port is adjacent the thoracic duct outlet.
27. The method of claim 24 , wherein the proximal and distal balloons are only expanded when drainage is required.